WallStSmart

Agroz Inc. Ordinary Shares (AGRZ)vsBunge Limited (BG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Bunge Limited generates 112103% more annual revenue ($70.33B vs $62.68M). AGRZ leads profitability with a 13.3% profit margin vs 1.2%. AGRZ trades at a lower P/E of 5.3x. BG earns a higher WallStSmart Score of 59/100 (C).

AGRZ

Buy

58

out of 100

Grade: C

Growth: 6.0Profit: 8.5Value: 8.3Quality: 6.0
Piotroski: 3/9Altman Z: 1.91

BG

Buy

59

out of 100

Grade: C

Growth: 5.3Profit: 4.0Value: 7.3Quality: 4.5
Piotroski: 1/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AGRZUndervalued (+33.0%)

Margin of Safety

+33.0%

Fair Value

$0.61

Current Price

$0.52

$0.09 discount

UndervaluedFair: $0.61Overvalued
BGSignificantly Overvalued (-264.1%)

Margin of Safety

-264.1%

Fair Value

$33.52

Current Price

$125.40

$91.88 premium

UndervaluedFair: $33.52Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AGRZ3 strengths · Avg: 9.3/10
P/E RatioValuation
5.3x10/10

Attractively priced relative to earnings

Return on EquityProfitability
85.9%10/10

Every $100 of equity generates 86 in profit

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

BG2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
75.5%10/10

Revenue surging 75.5% year-over-year

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

Areas to Watch

AGRZ4 concerns · Avg: 3.8/10
Revenue GrowthGrowth
3.2%4/10

3.2% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Altman Z-ScoreHealth
1.914/10

Grey zone — moderate risk

Market CapQuality
$10.34M3/10

Smaller company, higher risk/reward

BG4 concerns · Avg: 3.5/10
PEG RatioValuation
1.714/10

Expensive relative to growth rate

P/E RatioValuation
25.2x4/10

Moderate valuation

Return on EquityProfitability
6.0%3/10

ROE of 6.0% — below average capital efficiency

Profit MarginProfitability
1.2%3/10

1.2% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : AGRZ

The strongest argument for AGRZ centers on P/E Ratio, Return on Equity, Price/Book.

Bull Case : BG

The strongest argument for BG centers on Revenue Growth, Price/Book. Revenue growth of 75.5% demonstrates continued momentum.

Bear Case : AGRZ

The primary concerns for AGRZ are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : BG

The primary concerns for BG are PEG Ratio, P/E Ratio, Return on Equity. Thin 1.2% margins leave little buffer for downturns.

Key Dynamics to Monitor

AGRZ profiles as a value stock while BG is a hypergrowth play — different risk/reward profiles.

BG is growing revenue faster at 75.5% — sustainability is the question.

BG generates stronger free cash flow (799M), providing more financial flexibility.

Monitor FARM PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BG scores higher overall (59/100 vs 58/100) and 75.5% revenue growth. AGRZ offers better value entry with a 33.0% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Agroz Inc. Ordinary Shares

CONSUMER DEFENSIVE · FARM PRODUCTS · USA

Agroz Inc., an investment holding company, is a vertically integrated agricultural technology company in Malaysia. The company is headquartered in Petaling Jaya, Malaysia.

Bunge Limited

CONSUMER DEFENSIVE · FARM PRODUCTS · USA

Bunge Limited is a global food and agribusiness company. The company is headquartered in St. Louis, Missouri.

Want to dig deeper into these stocks?